MedTrace Logo

Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection

NCT00547352 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2007-10-22

No results posted yet for this study

Summary

To determine if men with problems getting and keeping an erection prefer treatment with tadalafil or sildenafil.

Conditions

  • Impotence

Interventions

DRUG

tadalafil

20 mg tadalafil tablets taken by mouth, as needed, no more than once a day for 8 weeks.

DRUG

sildenafil

Current users of sildenafil citrate for a minimum of 6 weeks prior to visit 1 will continue with an individual dosage to be taken no more than once a day for an additional 4 weeks.

Sponsors & Collaborators

Principal Investigators

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company

Study Design

Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Completion
2005-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00547352 on ClinicalTrials.gov